Apolipoprotein C3 induces inflammasome activation only in its delipidated form-Reference-Cited by-同舟云学术

Apolipoprotein C3 induces inflammasome activation only in its delipidated form

Published:2023-02-13 Issue:3 Volume:24 Page:408-411
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Hsu Cheng-Chieh^ORCID,Shao Baohai,Kanter Jenny E.,He Yi,Vaisar Tomas,Witztum Joseph L.,Snell-Bergeon Janet,McInnes Gregory^ORCID,Bruse Shannon,Gottesman Omri,Mullick Adam E.^ORCID,Bornfeldt Karin E.^ORCID

Funder

U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute

American Heart Association

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

https://www.nature.com/articles/s41590-023-01423-2.pdf

Reference28 articles.

1. Kanter, J. E. et al. Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes. J. Clin. Invest. 129, 4165–4179 (2019).

2. Basu, A. et al. Serum apolipoproteins and apolipoprotein-defined lipoprotein subclasses: a hypothesis-generating prospective study of cardiovascular events in T1D. J. Lipid Res. 60, 1432–1439 (2019).

3. Jansson Sigfrids, F. et al. Apolipoprotein C-III predicts cardiovascular events and mortality in individuals with type 1 diabetes and albuminuria. J. Intern. Med. 291, 338–349 (2022).

4. Scheffer, P. G. et al. Increased plasma apolipoprotein C-III concentration independently predicts cardiovascular mortality: the Hoorn Study. Clin. Chem. 54, 1325–1330 (2008).

5. TG and HDL Working Group of the Exome Sequencing Project, National Heart, Lung, and Blood Institute, et al. Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N. Engl. J. Med. 371, 22–31 (2014).

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreased Serum Apolipoprotein CIII in the Acute Phase of Kawasaki Disease;Pediatric Cardiology;2024-07-02

2. Elevated apolipoprotein C3 augments diabetic kidney disease and associated atherosclerosis in type 2 diabetes;JCI Insight;2024-05-14

3. APOC3 siRNA and ASO therapy for dyslipidemia;Current Opinion in Endocrinology, Diabetes & Obesity;2024-02-09

4. Apolipoprotein C3: form begets function;Journal of Lipid Research;2024-01

5. The analysis of serum lipids profile in Guillain-Barre syndrome;Frontiers in Immunology;2023-12-08